A tutorial on using real-world data and discrete event simulation to conduct premarket cost-effectiveness studies of new drugs
Abstract
This study explains how to perform a premarket cost‒utility analysis of a new treatment for a generic disease using a tutorial that combines discrete event simulation with real-world data (RWD).
Fields of Study & Subjects
Health Systems
Economic Evaluations
Quality of Life
Pharmaceutical Economics and Policy
Simulation Techniques and Applications
Publication details
- Journal / source
- OSF Preprints (OSF Preprints)
- Publication date
- 1 February 2026
- Document type
- Preprint